|
[Related PubMed/MEDLINE] Total Number of Papers: 10
|
|
|
[Display Entries]
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: alpha2,3-ST |
Long Form |
: alpha2,3-sialyltransferase |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2015 |
Chemo-enzymatic synthesis of imidazolium-tagged sialyllactosamine probes. |
alpha-2,6-ST |
2 |
2013 |
Effect of mild-thiol reducing agents and alpha2,3-sialyltransferase expression on secretion and sialylation of recombinant EPO in CHO cells. |
CHO, EPO, MESNA, NAC, TG, TLA |
3 |
2011 |
Alpha 1,3-galactosyltransferase deficiency in pigs increases sialyltransferase activities that potentially raise non-gal xenoantigenicity. |
alpha2,6ST, CMAH |
4 |
2011 |
Enhanced sialylation of recombinant human erythropoietin in Chinese hamster ovary cells by combinatorial engineering of selected genes. |
CHO, CMP, EPO, Gal, rh |
5 |
2010 |
Sialylation enhancement of CTLA4-Ig fusion protein in Chinese hamster ovary cells by dexamethasone. |
beta1,4-GT, CHO, DEX, GR |
6 |
2009 |
Enhanced sialylation of recombinant erythropoietin in CHO cells by human glycosyltransferase expression. |
beta1,4-GT, CHO, EPO |
7 |
2001 |
Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues. |
beta-1,4-GT, CMP-Sia, Sia, TNFR |
8 |
2000 |
Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms. |
beta1,4-GT, Gal, mRNA, NANA, TNFR-IgG |
9 |
1997 |
alpha2,3-sialyltransferase mRNA and alpha2,3-linked glycoprotein sialylation are increased in malignant gliomas. |
--- |
10 |
1996 |
Absorbance- and light-based solid-phase assays for CMPNeuAc:Galbeta1-4GlcNAc-R alpha-2,3-sialyltransferase. |
MAL |
|